Scott Juda - 01 Dec 2025 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Director
Signature
/s/ Scott Juda
Issuer symbol
INMB
Transactions as of
01 Dec 2025
Net transactions value
$0
Form type
4
Filing time
02 Dec 2025, 16:40:56 UTC
Previous filing
18 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Scott Juda filed Form 4 for Inmune Bio, Inc. (INMB) on 02 Dec 2025."

Quick Takeaways

  • This page summarizes Scott Juda's Form 4 filing for Inmune Bio, Inc. (INMB).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 02 Dec 2025, 16:40.

What Changed

  • Previous filing in this sequence was filed on 18 Nov 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Juda Scott Director C/O INMUNE BIO INC., 225 NE MIZNER BLVD., SUITE 640, BOCA RATON /s/ Scott Juda 02 Dec 2025 0001767084

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +150,000 $0.000000 150,000 01 Dec 2025 Common Stock 150,000 $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Issuer's Second Amended and Restated 2021 Stock Incentive Plan. The option will become vested and exercisable pro rata on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested, which shall occur on the three-year anniversary of the date of grant.

Sponsored